Dual-Energy Computed Tomography for Detection and Characterization of Monosodium Urate, Calcium Pyrophosphate, and Hydroxyapatite: A Phantom Study on Diagnostic Performance.


Journal

Investigative radiology
ISSN: 1536-0210
Titre abrégé: Invest Radiol
Pays: United States
ID NLM: 0045377

Informations de publication

Date de publication:
01 07 2021
Historique:
pubmed: 10 2 2021
medline: 16 10 2021
entrez: 9 2 2021
Statut: ppublish

Résumé

The aim of this study was to determine the diagnostic performance of dual-energy computed tomography (DECT) to detect and distinguish crystal deposits in a phantom. The primary objective was to determine the cutoff DECT ratio and the cross-sectional area (CSA) of a crystal deposit necessary to differentiate monosodium urate (MSU), calcium pyrophosphate (CPP), and calcium hydroxyapatite (HA) using DECT. Our secondary objective was to determine the concentration for limit of detection for MSU, CPP, and HA crystal deposits. Exploratory objectives included the comparison between 2 generations of DECT scanners from the same manufacturer as well as different scanner settings. We used a cylindrical soft tissue phantom with synthetic MSU, CPP, and HA crystals suspended in resin. Crystal suspension concentration increased with similar attenuation between MSU, CPP, and HA in conventional CT. The phantom was scanned on 2 dual-source DECT scanners, at 2 dose levels and all available tube voltage combinations. Both scanners had a tin (Sn) filter at the high-energy spectra. Dual-energy CT ratios were calculated for a given tube voltage combination by dividing linear regression lines of CT numbers against concentration. Dual-energy CT ratios were compared using an analysis of covariance. Receiver operating characteristic curves and corresponding areas under the curve (AUCs) were calculated for individual crystal suspension comparisons (HA vs CPP, MSU vs CPP, and MSU vs HA). At standard clinical scan settings with 8 mGy and 80/Sn150 kV, the DECT ratios were as follows: CPP, 2.02 (95% confidence interval [CI], 1.98-2.07); HA, 2.00 (95% CI, 1.96-2.05); and MSU, 1.09 (95% CI, 1.06-1.11). Ratios varied numerically depending on the scanner and tube voltage combination. Monosodium urate crystal DECT ratios were significantly different from HA and CPP (P < 0.001), whereas DECT ratios for HA and CPP crystals did not differ significantly (P = 0.99). The differentiation of MSU crystals from both calcium crystals (HA and CPP) was excellent with an AUC of 1.00 (95% CI, 1.00-1.00) and an optimal cutoff DECT ratio of 1.43:1.40 depending on the scanner. In addition, differentiation of MSU and calcium-containing crystals (HA and CPP) required a CSA of minimum 4 pixels of crystal at standard clinical scan conditions. In contrast, differentiation between CPP and HA crystals was moderate with AUCs ranging from 0.66 (95% CI, 0.52-0.80) to 0.80 (95% CI, 0.69-0.91) and an optimal cutoff DECT ratio of 2.02:2.06 depending on the scanner. Furthermore, differentiation between CPP and HA crystals required a CSA of minimum 87 pixels of crystal at standard clinical scan conditions, corresponding to a region of interest of 3.7 mm diameter. When scanning at highest possible spectral separation and maximum dose of 50 mGy, the limit of detection for crystals within a region of interest of 50 pixels was 14 mg/cm3 for MSU and 2 mg/cm3 for both CPP and HA. This phantom study shows that DECT can be used to detect MSU, CPP, and HA crystal deposits. Differentiation of CPP and HA was not possible in crystals deposits less than 3.7 mm in diameter, but MSU could accurately be differentiated from CPP and HA crystal deposits at standard clinical scan conditions.

Identifiants

pubmed: 33559986
pii: 00004424-202107000-00002
doi: 10.1097/RLI.0000000000000756
doi:

Substances chimiques

Uric Acid 268B43MJ25
Durapatite 91D9GV0Z28
Calcium Pyrophosphate X69NU20D19

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

417-424

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest and sources of funding: A.D., L.S., H.B., and M.B. have no conflicts of interest to declare. F.C.M. is an employee of Siemens Healthineers. F.B. has a research agreement for DECT with Siemens Healthineers. A.D. is supported by the IMK Foundation, the A.P. Møller Foundation, the Aase and Ejnar Danielsen's Foundation, and the Danish Medical Association. The Parker Institute is also supported by a core grant from the Oak Foundation (OCAY-18-774-OFIL).

Références

Rutherford RA, Pullan BR, Isherwood I. X-ray energies for effective atomic number determination. Neuroradiology . 1976;11:23–28.
Neogi T, Jansen TL, Dalbeth N, et al. 2015 gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheumatol . 2015;67:2557–2568.
Richette P, Doherty M, Pascual E, et al. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis . 2019;79:31–38.
Gibilisco PA, Schumacher HR Jr., Hollander JL, et al. Synovial fluid crystals in osteoarthritis. Arthritis Rheum . 1985;28:511–515.
Corr EM, Cunningham CC, Helbert L, et al. Osteoarthritis-associated basic calcium phosphate crystals activate membrane proximal kinases in human innate immune cells. Arthritis Res Ther . 2017;19:23.
Cunningham CC, Mills E, Mielke LA, et al. Osteoarthritis-associated basic calcium phosphate crystals induce pro-inflammatory cytokines and damage-associated molecules via activation of Syk and PI3 kinase. Clin Immunol . 2012;144:228–236.
McCarthy GM, Dunne A. Calcium crystal deposition diseases—beyond gout. Nat Rev Rheumatol . 2018;14:592–602.
Stack J, McCarthy G. Basic calcium phosphate crystals and osteoarthritis pathogenesis: novel pathways and potential targets. Curr Opin Rheumatol . 2016;28:122–126.
Nalbant S, Martinez JA, Kitumnuaypong T, et al. Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. Osteoarthritis Cartilage . 2003;11:50–54.
Diekhoff T, Kiefer T, Stroux A, et al. Detection and characterization of crystal suspensions using single-source dual-energy computed tomography: a phantom model of crystal arthropathies. Invest Radiol . 2015;50:255–260.
Tanikawa H, Ogawa R, Okuma K, et al. Detection of calcium pyrophosphate dihydrate crystals in knee meniscus by dual-energy computed tomography. J Orthop Surg Res . 2018;13:73.
Ziegeler K, Hermann S, Hermann KGA, et al. Dual-energy CT in the differentiation of crystal depositions of the wrist: does it have added value? Skeletal Radiol . 2020;49:707–713.
MacMullan P, McMahon G, McCarthy G. Detection of basic calcium phosphate crystals in osteoarthritis. Joint Bone Spine . 2011;78:358–363.
Huber FA, Becce F, Gkoumas S, et al. Differentiation of crystals associated with arthropathies by spectral photon-counting radiography: a proof-of-concept study. Invest Radiol . 2020. doi: 10.1097/RLI.0000000000000717. [Epub ahead of print].
doi: 10.1097/RLI.0000000000000717.
Park EH, Yoo WH, Song YS, et al. Not all green is tophi: the importance of optimizing minimum attenuation and using a tin filter to minimize clumpy artifacts on foot and ankle dual-energy CT. Am J Roentgenol . 2020;214:1335–1342.
Christiansen SN, Müller FC, Østergaard M, et al. Dual-energy CT in gout patients: do all colour-coded lesions actually represent monosodium urate crystals? Arthritis Res Ther . 2020;22:212.
Pascart T, Norberciak L, Legrand J, et al. Dual-energy computed tomography in calcium pyrophosphate deposition: initial clinical experience. Osteoarthr Cartil . 2019;27:1309–1314.
Pascart T, Falgayrac G, Norberciak L, et al. Dual-energy computed-tomography-based discrimination between basic calcium phosphate and calcium pyrophosphate crystal deposition in vivo. Ther Adv Musculoskelet Dis . 2020;12:1759720X20936060.
Krauss B, Grant KL, Schmidt BT, et al. The importance of spectral separation: an assessment of dual-energy spectral separation for quantitative ability and dose efficiency. Invest Radiol . 2015;50:114–118.
Youden WJ. Index for rating diagnostic tests. Cancer . 1950;3:32–35.
Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev . 2008;29 Suppl 1:S49–S52.
Rutherford RA, Pullan BR, Isherwood I. Measurement of effective atomic number and electron density using an EMI scanner. Neuroradiology . 1976;11:15–21.
Stamp LK, Anderson NG, Becce F, et al. Clinical utility of multi-energy spectral photon-counting computed tomography in crystal arthritis. Arthritis Rheumatol . 2019;71:1158–1162.
Blanton PL, Biggs NL. Density of fresh and embalmed human compact and cancellous bone. Am J Phys Anthropol . 1968;29:39–44.
Budzik JF, Marzin C, Legrand J, et al. Is dual-energy computed tomography able to identify early calcium crystal deposition in the knees of calcium pyrophosphate deposition patients? Arthritis Rheumatol . 2020. doi: 10.1002/art.41569. [Epub ahead of print].
doi: 10.1002/art.41569.
Diekhoff T, Kotlyarov M, Mews J, et al. Iterative reconstruction may improve diagnosis of gout: an ex vivo (bio) phantom dual-energy computed tomography study. Invest Radiol . 2018;53:6–12.
Racine D, Becce F, Viry A, et al. Task-based characterization of a deep learning image reconstruction and comparison with filtered back-projection and a partial model-based iterative reconstruction in abdominal CT: a phantom study. Phys Med . 2020;76:28–37.
Lell MM, Kachelrieß M. Recent and upcoming technological developments in computed tomography: high speed, low dose, deep learning, multienergy. Invest Radiol . 2020;55:8–19.
Willemink MJ, Persson M, Pourmorteza A, et al. Photon-counting CT: technical principles and clinical prospects. Radiology . 2018;289:293–312.
Hurrell MA, Butler APH, Cook NJ, et al. Spectral Hounsfield units: a new radiological concept. Eur Radiol . 2012;22:1008–1013.
Becce F, Viry A, Stamp LK, et al. Winds of change in imaging of calcium crystal deposition diseases. Joint Bone Spine . 2019;86:665–668.
Jacobsen MC, Schellingerhout D, Wood CA, et al. Intermanufacturer comparison of dual-energy CT iodine quantification and monochromatic attenuation: a phantom study. Radiology . 2018;287:224–234.
Yu K, Lien L, Ho H. Limited knee joint range of motion due to invisible gouty tophi. Rheumatology . 2004;43:191–194.
Schneider U, Pedroni E, Lomax A. The calibration of CT Hounsfield units for radiotherapy treatment planning. Phys Med Biol . 1996;41:111–124.
Ea HK, Gauffenic A, Nguyen QD, et al. Calcium pyrophosphate dihydrate crystal deposition in gouty tophi. Arthritis Rheumatol . 2020. doi: 10.1002/art.41515. [Epub ahead of print].
doi: 10.1002/art.41515.
Hajri R, Hajdu SD, Hügle T, et al. Dual-energy computed tomography for the noninvasive diagnosis of coexisting gout and calcium pyrophosphate deposition disease. Arthritis Rheumatol . 2019;71:1392.
Obmann MM, Kelsch V, Cosentino A, et al. Interscanner and intrascanner comparison of virtual unenhanced attenuation values derived from twin beam dual-energy and dual-source, dual-energy computed tomography. Invest Radiol . 2019;54:1–6.
Filippou G, Scanu A, Adinolfi A, et al. Criterion validity of ultrasound in the identification of calcium pyrophosphate crystal deposits at the knee: an OMERACT ultrasound study. Ann Rheum Dis . 2020;annrheumdis-2020-217998. doi: 10.1136/annrheumdis-2020-217998. [Epub ahead of print].
doi: 10.1136/annrheumdis-2020-217998.

Auteurs

Anna Døssing (A)

From the The Parker Institute, Bispebjerg and Frederiksberg Hospital.

Felix Christoph Müller (FC)

Department of Radiology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.

Fabio Becce (F)

Department of Diagnostic and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Lisa Stamp (L)

Department of Medicine, University of Otago, Christchurch, New Zealand.

Henning Bliddal (H)

From the The Parker Institute, Bispebjerg and Frederiksberg Hospital.

Mikael Boesen (M)

Department of Radiology, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH